 |
| Contact us |
|
| sanofi-aventis U.S. |
55 Corporate Drive
Bridgewater, NJ 08807
Tel: 800-981-2491
|
| Via email |
|
|
|
|
|
Sanofi-aventis U.S., based in Bridgewater, NJ, and employing 16,000 people across the country, is part of a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people’s lives. Our extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders and vaccines.
|
|
| Building blocks for growth and innovation: |
|
Sanofi-aventis currently ranks among the top pharmaceutical companies in the U.S. The company's seven U.S. blockbusters and most widely prescribed products include: - Lovenox® (enoxaparin sodium injection)
- Plavix® (clopidogrel bisulfate)
- Ambien® CIV/Ambien CR™ (zolpidem tartrate)
- Taxotere® (docetaxel)
- Eloxatin® (oxaliplatin injection)
- Lantus® (insulin glargine [rDNA origin] injection)
- Copaxone® (glatiramer acetate for injection)
|
| On the pathway to success |
|
Sanofi-aventis has four U.S.-based R&D sites that employ approximately 2,500 scientists, physicians and support staff. The Bridgewater, NJ site covers all aspects of R&D and the Great Valley, PA site is involved in pre-clinical, clinical and regulatory affairs activities. The Tucson Center specializes in combinatorial technologies and the Cambridge, MA site in genomics research.
|
| Last update: May 16, 2008 |
|
|
|
